Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clinical study proves benefits of joint supplements on canine mobility
Dr Matthew Pead and Dr John Howie at the BSAVA congress.
Dr Matthew Pead and Dr John Howie at the BSAVA congress.

Royal Veterinary College study found "significant" improvements over six week period

The Royal Veterinary College says it has found the first ever clinical proof of the effect of joint supplements on canine mobility.

The college carried out a two and a half year long clinical study.

Monitors originally developed to track wild cat movements in Africa were instead applied to measure the activity of dogs over a six week period.

One set of dogs were given the YUMOVE supplement, and another group a placebo. The group that were given YUMOVE showed statistically significant improvements , the college said.

"This study represents a major step forward in canine mobility”, said Dr Matthew Pead, lead investigator at the RVC.

“It took nine months of careful planning to ensure a robust methodology was developed to provide clear clinical results that veterinary professionals can rely on, and give confidence when recommending joint supplements to dog owners.

"Furthermore, the huge volume of objective activity data will enhance our understanding of the effect of canine osteoarthritis on mobility and activity in the dog’s day to day activities.”

The clinical study was sponsored by Lintbells, the UK based manufacturer of YUMOVE.

“We are very excited by the results of the clinical study” said Lintbells co-founder Dr John Howie.

“From the extensive feedback from owners and vets alike, we already knew the product worked.

"But we wanted to establish independent, rigorous clinical evidence for YUMOVE so that veterinary professionals could recommend the product with confidence, and dog owners knew what to expect from a clinically proven joint supplement in real-life situations.

"There is a great deal of uncertainty and confusion when it comes to joint supplements. This clinical study now provides clarity for clinician and owner alike.

"With an estimated 1.2 million dogs suffering from joint and mobility issues and only approximately 10 to 15 per cent receiving a nutritional supplement, Lintbells believes that providing an affordable, proven product that owners can rely on will uncap the significant market opportunity for veterinary professionals.”

 

Become a member or log in to add this story to your CPD history

Survey launched to investigate EHV

News Story 1
 Zoetis has launched a new survey to identify management techniques for Equine Herpes Virus (EHV).

EHV is a contagious, airborne virus that can cause respiratory problems and severe diseases in horses and ponies. It spreads among horses over short distances, direct contact and through shared equipment.

The survey will explore current knowledge and management practices with EHV in the UK. It is quick to complete and participants could win one of 10 equine first aid kits.

Complete the survey here

Click here for more...
News Shorts
WSAVA launches pet travel guidance factsheet

A new pet travel guidance factsheet for veterinary professionals and caregivers has been developed by the WSAVA in collaboration with the World Veterinary Association.

The Dog and Cat Welfare During Transport factsheet provides step-by-step guidance for all stages of a journey, from pre-travel checklists to post-travel care.

Brachycephalic breeds or animals prone to travel-related anxiety are given special focus in this guide, which also provides links to IATA container regulation and WSAVA vaccination guidelines.